Follow

Submissions from 2016

PDF

Development of a novel renal activity index of lupus nephritis in children & young adults, H. I. Brunner, M. Bennett, K. Abulaban, M. Klein-Gitelman, K. O'Neil, L. Tucker, S. Ardoin, K. Rouster-Stevens, B. A. Eberhard, P. Devarajan, and +8 additional authors

PDF

Validation of the lupus nephritis clinical indices in childhood-onset systemic lupus erythematosus, R. Mina, K. Abulaban, M. Klein-Gitelman, A. Eberhard, S. Ardoin, N. Singer, K. Onel, L. Tucker, K. O'Neil, H. I. Brunner, and +8 additional authors

Submissions from 2015

PDF

Effects of obesity on health-related quality of life in juvenile-onset systemic lupus erythematosus, R. Mina, M. S. Klein-Gitelman, S. Nelson, B. A. Eberhard, G. Higgins, N. G. Singer, K. Onel, L. Tucker, K. M. O'Neil, H. I. Brunner, and +4 additional authors

Link

Efficacy of an Interinstitutional Mentoring Program Within Pediatric Rheumatology., L. N. Moorthy, E. Muscal, M. Riebschleger, M. Klein-Gitelman, L. E. Nigrovic, J. R. Horon, K. Rouster-Stevens, P. J. Ferguson, B. A. Eberhard, P. A. Nigrovic, and +3 additional authors

Link

Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project, S. Ringold, A. Hendrickson, L. Abramson, T. Beukelman, P. R. Blier, J. Bohnsack, E. C. Chalom, H. L. Gewanter, B. Gottlieb, R. E. Sobel, and +26 additional authors

Submissions from 2014

PDF

Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis, N. T. Ilowite, K. Prather, Y. Lokhnygina, L. E. Schanberg, M. Elder, D. Milojevic, J. W. Verbsky, S. J. Spalding, B. S. Gottlieb, C. I. Sandborg, and +12 additional authors

Link

AMIGO: A Novel Approach to the Mentorship Gap in Pediatric Rheumatology, P. A. Nigrovic, E. Muscal, M. Riebschleger, L. N. Moorthy, H. I. Brunner, B. A. Eberhard, M. Klein-Gitelman, S. Prahalad, and R. Schneider

PDF

Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the phase 4 registry, R. E. Sobel, D. J. Lovell, H. I. Brunner, J. E. Weiss, P. W. Morris, B. S. Gottlieb, E. C. Chalom, L. K. Jung, K. B. Onel, E. H. Giannini, and +6 additional authors

Link

Clinically Inactive Disease in a Cohort of Children with New-onset Polyarticular Juvenile Idiopathic Arthritis Treated with Early Aggressive Therapy: Time to Achievement, Total Duration, and Predictors, C. A. Wallace, E. H. Giannini, S. J. Spalding, P. J. Hashkes, K. M. O'Neil, A. S. Zeft, I. S. Szer, S. Ringold, B. S. Gottlieb, D. J. Lovell, and +12 additional authors

Link

Extension study of participants from the trial of early aggressive therapy in juvenile idiopathic arthritis, C. A. Wallace, S. Ringold, J. Bohnsack, S. J. Spalding, H. I. Brunner, D. Milojevic, L. E. Schanberg, G. C. Higgins, B. S. Gottlieb, A. Hendrickson, and +4 additional authors